GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
GANX fundamentals
Gain Therapeutics (GANX) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.19 (YoY +54.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.19
+54.76%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.EPS
Actual | -0.31 | -0.3 | -0.39 | -0.2687 | -0.28 | -0.43 | -0.38 | -0.39 | -0.43 | -0.62 | -0.37 | -0.29 | -0.22 | -0.42 | -0.17 | -0.08 | -0.16 | -0.19 |
Forecast | -0.3167 | -0.2656 | -0.3551 | -0.4808 | -0.3478 | -0.3025 | -0.4475 | -0.3648 | -0.394 | -0.3079 | -0.446 | -0.312 | -0.3108 | -0.1948 | -0.2072 | -0.1837 | -0.1798 | -0.1667 |
Surprise | +2.12% | -12.95% | -9.83% | +44.11% | +19.49% | -42.15% | +15.08% | -6.91% | -9.14% | -101.36% | +17.04% | +7.05% | +29.21% | -115.61% | +17.95% | +56.45% | +11.01% | -13.98% |
Revenue
Actual | 5.30K | 89.17K | 27.34K | 43.00K | 45.01K | 95.10K | 0 | 0 | 55.18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | 20.00K | 51.60K | 39.00K | 31.67K | 51.50K | 0 | 10.00K | 1.01M | 337.50K | 250.00K | 120.00K | 400.00K | 10.00K | 0 | 25.00K | 0 |
Surprise | 0.00% | 0.00% | +36.73% | -16.67% | +15.40% | +200.32% | -100.00% | 0.00% | +451.80% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | 0.00% | -100.00% | 0.00% |
Earnings Call
You can ask Aime
What is Gain Therapeutics's gross profit margin?What guidance did Gain Therapeutics's management provide for the next earnings period?What were the key takeaways from Gain Therapeutics’s earnings call?What is the market's earnings forecast for Gain Therapeutics next quarter?What is the revenue and EPS growth rate for Gain Therapeutics year over year?Did Gain Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Gain Therapeutics's earnings call?What does Gain Therapeutics do and what are its main business segments?
